Press
Announcements
Genomind is Advancing how Healthcare Providers Prescribe Medications Better, Faster – Expanding Beyond Mental Health
Genomind is expanding its genetic panel and introducing a new streamlined report with actionable insights for patients – the Express Report
Shore Quality Partners Teams with Genomind to Help Prevent Adverse Prescription Drug Events
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
Genomind Pharmacogenetic Population Health Tool Highlighted in American Journal of Managed Care and 22nd Population Health Colloquium
Innovative approach addresses a huge and costly public health burden.
Genomind Completes Integration with Epic with support from Parkview Physicians Group
Parkview providers now able to order Genomind testing and view results within their Epic EHR system.
Cosán and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
David Nash MD to Join Genomind’s Scientific Advisory Board
Genomind®, a leading precision healthcare company named David Nash, MD, MBA of Jefferson Health the newest member of its Scientific Advisory Board (SAB).
Harmony United Psychiatric Care Enhances Behavioral Health Services with Genomind’s Precision Digital Mental Health Platform
Leading behavioral health practice Harmony United Psychiatric Care has integrated Genomind’s pharmacogenomic testing and services into Mendent EMR system.